PhD Gregor Serša

PhD Gregor Serša
no.: 08800 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • German
  • Reading: Functional
  • Writing: Basic
  • Speaking: Functional
  • Italian
  • Reading: Basic
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Experimental oncology, radiobiology, drug delivery, electrochemotherapy, vinblastine, bleomicyn, cisplatine
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
2,238.44
A''
59.31
A'
920.88
A1/2
1,345.02
CI10
9,071
CImax
617
h10
45
A1
6.55
A3
5
Data for the last 5 years (citations for the last 10 years) on December 4, 2025; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 381  14,022  10,012  26.28 
Scopus 411  16,807  12,300  29.93 
Audiovisual sources
no. Title (with video link) Event Source
1. Development and evaluation of new approaches to cancer treatment     Research programme video presentation 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Jerneja Kos   Bologna doctoral studies  10/1/2017 - 9/30/2022  50592 
2 PhD Katja Uršič Valentinuzzi   Bologna doctoral studies  10/1/2015 - 6/30/2019  38223 
3 PhD Ajda Prevc   Bologna doctoral studies  11/1/2014 - 8/31/2018  37415 
4 PhD Špela Kos   Bologna doctoral studies  10/1/2013 - 3/31/2017  36366 
5 PhD Monika Savarin   Bologna doctoral studies  12/1/2012 - 3/31/2017  35355 
6 PhD Maša Omerzel   Bologna doctoral studies  11/1/2011 - 4/30/2015  34373 
7 PhD Aleš Sedlar   Bologna doctoral studies  10/1/2009 - 3/31/2013  32176 
8 PhD Urška Kamenšek   Uniform doctoral studies  11/1/2006 - 4/30/2010  28387 
9 PhD Suzana Vidic   Uniform doctoral studies  10/1/2004 - 3/31/2009  24444 
10 PhD Alenka Grošel   Doctoral degree  11/1/2000 - 4/30/2005  21329 
11 PhD Simona Kranjc Brezar   Doctoral degree  11/1/1998 - 10/31/2003  19058 
12 PhD Maja Čemažar   Doctoral degree  12/15/1993 - 11/30/1998  14575 
13 PhD Barbara Jezeršek Novaković   Doctoral degree  5/1/1991 - 5/31/1998  12022 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Physiology  SI University of Ljubljana, Biotechnical Faculty 1979 
Master's degree    Immunology  SI University of Ljubljana, Faculty of Medicine 1985 
Doctoral degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Medicine 1988 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research  9/19/1979    Researcher  Full professor 
Full time employment (20%, RD:0%)  University of Ljubljana, Faculty of Health Sciences  Biomedical Research Group  10/1/2016  Associate professor  Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-60068  Circulating tumor cell translational research platform.   1/1/2025 - 12/31/2027  PhD Tanja Jesenko   3,006 
2. J1-60017  Perfusion, Edema, and Necrosis Evaluation using OCT for Tumor Outcome Measures   1/1/2025 - 12/31/2027  PhD Jošt Stergar   2,819 
3. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   10/1/2023 - 9/30/2026  PhD Katarina Žnidar   2,463 
4. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   10/1/2023 - 9/30/2026  PhD Nina Kostevšek   4,318 
5. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   10/1/2023 - 9/30/2026  PhD Maja Čemažar   3,118 
6. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   10/1/2023 - 9/30/2026  PhD Katja Uršič Valentinuzzi   3,463 
7. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   10/1/2023 - 9/30/2026  PhD Matej Reberšek   3,806 
8. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,830 
9. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   10/1/2022 - 9/30/2025  PhD Igor Muševič   6,063 
10. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   10/1/2022 - 9/30/2025  PhD Matej Sova   4,370 
11. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,468 
12. BI-US/22-24-026  Biomarkers to aid the efficacy of electrochemotherapy in combination with immunogenic therapy for cancer treatment   7/1/2022 - 6/30/2024  PhD Gregor Serša   1,625 
13. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   9/1/2020 - 8/31/2023  PhD Maja Čemažar   3,510 
14. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   9/1/2020 - 8/31/2023  PhD Nataša Tozon Mask   3,967 
15. J3-2529  Role of endothelium in tumor response to radiotherapy   9/1/2020 - 8/31/2023  PhD Boštjan Markelc   3,819 
16. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   9/1/2020 - 8/31/2023  PhD Mateja Erdani Kreft   5,737 
17. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   7/1/2018 - 6/30/2021  PhD Gregor Serša   3,936 
18. J2-9225  Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields   7/1/2018 - 6/30/2021  PhD Damijan Miklavčič   3,126 
19. N3-0059  Plasma-assisted wound treatment and topical introduction of molecules   1/1/2017 - 12/31/2020  PhD Uroš Cvelbar   3,385 
20. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)   5/1/2017 - 4/30/2020  PhD Janko Kos   5,176 
21. J3-8202  Spremljanje imunskega odziva v realnem času po in situ vakcinaciji z elektrokemoterapijo in pridruženo gensko terapijo z interlevkinom-12 (Slovene)   5/1/2017 - 4/30/2020  PhD Maja Čemažar   3,892 
22. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   3/1/2016 - 2/28/2019  PhD Igor Emri   4,762 
23. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   1/1/2016 - 12/31/2018  PhD Primož Strojan   4,650 
24. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   1/1/2016 - 12/31/2018  PhD Mateja Erdani Kreft   7,741 
25. J1-6730  Razvoj novih celičnih linij človeških jeter za raziskave genotoksičnosti in karcinogenosti: novo upanje za človekovo zdravje in zaščito laboratorijskih živali (Slovene)   11/1/2014 - 10/31/2017  PhD Metka Filipič   4,490 
26. J3-6793  Novi pristopi radiosenzibilizacije tumorjev z gensko terapijo (Slovene)   7/1/2014 - 6/30/2017  PhD Gregor Serša   5,591 
27. J1-6744  Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene)   7/1/2014 - 6/30/2017  PhD Tina Kosjek   5,363 
28. J3-6796  Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov (Slovene)   7/1/2014 - 6/30/2017  PhD Maja Čemažar   5,338 
29. J3-5505  Elektrokemoterapija globoko ležečih tumorjev (Slovene)   8/1/2013 - 7/31/2016  PhD Gregor Serša   4,639 
30. J4-5529  Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene)   8/1/2013 - 7/31/2016  PhD Janko Kos   6,650 
31. J3-4211  Antiangiogena genska terapija raka: tarčno zdravljenje z uporabo elektroporacije in magnetnih nanodelcev kot dostavnih sistemov (Slovene)   7/1/2011 - 6/30/2014  PhD Gregor Serša   7,012 
32. J1-4044  Apoptotično delovanje alkilpiridinijevih spojin na celice pljučnega adenokarcinoma (Slovene)   7/1/2011 - 6/30/2014  PhD Tom Turk   6,802 
33. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,431 
34. L2-4105  Razvoj programa za numerično modeliranje elektroporacije in vivo ter njegova validacija? in silico elektroporacija (Slovene)   7/1/2011 - 6/30/2014  PhD Damijan Miklavčič   5,264 
35. J1-4131  Sinteza, karakterizacija in uporaba novih rutenijevih spojin v elektrokemoterapiji tumorjev (Slovene)   7/1/2011 - 6/30/2014  PhD Iztok Turel   6,539 
36. J2-3639  Novi lipidni modelni sistemi za določitev mehanizmov elektroporacije (Slovene)   5/1/2010 - 4/30/2013  PhD Damijan Miklavčič   5,628 
37. J3-2069  Uporaba magnetne nanotehnologije za transfekcijo normalnih in tumorskih celic (Slovene)   5/1/2009 - 4/30/2012  PhD Gregor Serša   2,978 
38. J1-0200  Sinteza novih rutenijevih spojin in njihova možna uporaba pri tumorski elektrokemoterapiji (Slovene)   2/1/2008 - 1/31/2011  PhD Iztok Turel   4,684 
39. J3-0485  Antiangiogenic siRNA for the treatment of advanced malignant melanoma   2/1/2008 - 1/30/2011  PhD Maja Čemažar   2,810 
40. J3-9580  Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens   1/1/2007 - 12/31/2009  PhD Gregor Serša   2,712 
41. M1-0153  Biološka dozimetrija na osnovi magnetno resonančnih metod (Slovene)   6/1/2006 - 11/30/2008  PhD Marjeta Šentjurc   7,613 
42. V3-0371  Znanstveno raziskovalni zavodi na področju biomedicinskih znanosti - izsledki biomedicinskih raziskav in učinkovita oblika organiziranosti (Slovene)   10/1/2006 - 9/30/2008  PhD Bojan Zalar   5,346 
43. J3-7044  Treatment of malignant tumours with electrogene therapy   9/1/2005 - 8/31/2008  PhD Maja Čemažar   3,577 
44. J3-6443  Metodologija za analizo scientometričnih podatkov v medicini (Slovene)   7/1/2004 - 6/30/2007  PhD Štefan Adamič   4,515 
45. J3-6260  Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene)   2/1/2004 - 1/30/2007  PhD Marija Auersperg   4,751 
46. J3-4291  Napovedni pomen proteinov uPA sistema za odgovor na sistemsko zdravljenje in za lokalno ponovitev bolezni pri bolnicah z rakom dojk (Slovene)   7/1/2002 - 6/30/2005  PhD Tanja Čufer   4,727 
47. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   7/1/2002 - 6/30/2005  PhD Maja Čemažar   5,147 
48. J3-3501  Creation of tumor vaccines   7/1/2001 - 6/30/2004  PhD Srdjan Novaković   3,662 
49. L3-3375  Introduction of threedimensional radiotherapy treatment planning in Slovenia   7/1/2001 - 6/30/2004  PhD Hotimir Lešničar   6,414 
50. J3-3489  New biomedical applications of electroporation   7/1/2001 - 6/30/2004  PhD Gregor Serša   4,335 
51. J3-3026  Role of cytomorphology, DNA measurements, Ki 67 and apoptosis for planning and predicting the effect of chemotherapy in thyroid cancer   7/1/2001 - 6/30/2004  PhD Ana Pogačnik   3,707 
52. J3-2165  Napovedni pomen proteinov uPA sistema in katepsinov za prezivetje in odgovor na sistemsko zdravljenje bolnic z rakom dojk (Slovene)   1/1/2000 - 6/30/2002  PhD Tanja Čufer   4,792 
53. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   1/1/2000 - 6/30/2002  PhD Maja Čemažar   4,402 
54. J3-0123  Protitelesa proti proteinu p53 in p53 v serumu bolnikov z malignimi tumorji (Slovene)   7/1/1998 - 6/30/2001  PhD Zvonimir Rudolf   3,861 
55. J3-7843  Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene)   1/1/1996 - 6/30/2001  PhD Gregor Serša   4,387 
56. J3-7842  Racionalna diagnostika in zdravljenje tumorjev ščitnice (Slovene)   1/1/1996 - 6/30/2001  PhD Nikola Bešić   3,110 
57. J3-7878  Razvoj avtolognih tumorskih vakcin (Slovene)   1/1/1996 - 6/30/2001  PhD Srdjan Novaković   5,961 
58. L1-0469  Optimization of MDP and TNF analogues having therapeutic potential   7/1/1998 - 6/30/2000  PhD Anton Štalc   6,605 
59. J3-8679  Apoptosis and the immune system   1/1/1997 - 12/31/1999  PhD Vladimir Kotnik   6,853 
60. J3-8748  Boron Neutron Capture Therapy - Employment of drug delivery systems for increased antitumor effectiveness   1/1/1997 - 12/31/1999  PhD Janez Škrk   5,206 
61. J3-8746  Prognostic value of uPA, PAI 1 and PAI 2 in solid tumors   1/1/1997 - 12/31/1999  PhD Tanja Čufer   4,137 
62. L1-7379  Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)   1/1/1996 - 6/30/1998  PhD Anton Štalc   6,338 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2022 - 12/31/2027 PhD Gregor Serša   4,512 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,621 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2009 - 12/31/2014 PhD Gregor Serša   4,381 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   7/1/2004 - 12/31/2008 PhD Gregor Serša   3,340 
Confirmation required
Views history
Favourite